JP2023537895A5 - - Google Patents
Info
- Publication number
- JP2023537895A5 JP2023537895A5 JP2023507508A JP2023507508A JP2023537895A5 JP 2023537895 A5 JP2023537895 A5 JP 2023537895A5 JP 2023507508 A JP2023507508 A JP 2023507508A JP 2023507508 A JP2023507508 A JP 2023507508A JP 2023537895 A5 JP2023537895 A5 JP 2023537895A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0102604 | 2020-08-14 | ||
| KR20200102604 | 2020-08-14 | ||
| PCT/KR2021/010780 WO2022035271A1 (ko) | 2020-08-14 | 2021-08-13 | 삼중 활성체 지속형 결합체를 유효성분으로 포함하는 약학 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023537895A JP2023537895A (ja) | 2023-09-06 |
| JP2023537895A5 true JP2023537895A5 (https=) | 2024-08-20 |
| JPWO2022035271A5 JPWO2022035271A5 (https=) | 2024-08-20 |
Family
ID=80247218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507508A Pending JP2023537895A (ja) | 2020-08-14 | 2021-08-13 | 三重活性体持続型結合体を有効成分として含む薬学組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230302148A1 (https=) |
| EP (1) | EP4197560A4 (https=) |
| JP (1) | JP2023537895A (https=) |
| KR (1) | KR20220021890A (https=) |
| AU (1) | AU2021324792A1 (https=) |
| CA (1) | CA3187742A1 (https=) |
| IL (1) | IL299800A (https=) |
| MX (1) | MX2023001599A (https=) |
| TW (1) | TW202220700A (https=) |
| WO (1) | WO2022035271A1 (https=) |
| ZA (1) | ZA202301081B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4197550A4 (en) * | 2020-08-14 | 2025-10-08 | Hanmi Pharmaceutical Co Ltd | PHARMACEUTICAL COMPOSITION WITH HYPOTENSIVE EFFECT COMPRISING A TRIPLE ACTIVATOR WITH ACTIVITY FOR ALL GLUCAGON, GLP-1, AND GIP RECEPTORS |
| KR20230004135A (ko) * | 2021-06-30 | 2023-01-06 | 한미약품 주식회사 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체를 포함하는 조합물의 치료학적 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| SG191252A1 (en) * | 2010-12-22 | 2013-07-31 | Marcadia Biotech Inc | Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides |
| KR102041412B1 (ko) * | 2011-12-30 | 2019-11-11 | 한미사이언스 주식회사 | 면역글로불린 Ｆｃ 단편 유도체 |
| CA2877358A1 (en) * | 2012-06-21 | 2013-12-27 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting gip receptor activity |
| AU2014345570B2 (en) * | 2013-11-06 | 2019-01-24 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
| WO2017116204A1 (ko) * | 2015-12-31 | 2017-07-06 | 한미약품 주식회사 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 |
| TWI767095B (zh) * | 2017-12-21 | 2022-06-11 | 美商美國禮來大藥廠 | 腸促胰島素(incretin)類似物及其用途 |
| EP4197550A4 (en) * | 2020-08-14 | 2025-10-08 | Hanmi Pharmaceutical Co Ltd | PHARMACEUTICAL COMPOSITION WITH HYPOTENSIVE EFFECT COMPRISING A TRIPLE ACTIVATOR WITH ACTIVITY FOR ALL GLUCAGON, GLP-1, AND GIP RECEPTORS |
-
2021
- 2021-08-13 MX MX2023001599A patent/MX2023001599A/es unknown
- 2021-08-13 IL IL299800A patent/IL299800A/en unknown
- 2021-08-13 AU AU2021324792A patent/AU2021324792A1/en active Pending
- 2021-08-13 WO PCT/KR2021/010780 patent/WO2022035271A1/ko not_active Ceased
- 2021-08-13 KR KR1020210107599A patent/KR20220021890A/ko active Pending
- 2021-08-13 US US18/040,869 patent/US20230302148A1/en active Pending
- 2021-08-13 CA CA3187742A patent/CA3187742A1/en active Pending
- 2021-08-13 JP JP2023507508A patent/JP2023537895A/ja active Pending
- 2021-08-13 EP EP21856277.5A patent/EP4197560A4/en active Pending
- 2021-08-13 TW TW110129971A patent/TW202220700A/zh unknown
-
2023
- 2023-01-25 ZA ZA2023/01081A patent/ZA202301081B/en unknown